Cargando…
Senotherapeutics: emerging strategy for healthy aging and age-related disease
Cellular senescence (CS) is one of hallmarks of aging and accumulation of senescent cells (SCs) with age contributes to tissue or organismal aging, as well as the pathophysiologies of diverse age-related diseases (ARDs). Genetic ablation of SCs in tissues lengthened health span and reduced the risk...
Autores principales: | Kim, Eok-Cheon, Kim, Jae-Ryong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386227/ https://www.ncbi.nlm.nih.gov/pubmed/30526770 http://dx.doi.org/10.5483/BMBRep.2019.52.1.293 |
Ejemplares similares
-
Senotherapeutics and Their Molecular Mechanism for Improving Aging
por: Park, Jooho, et al.
Publicado: (2022) -
Senotherapeutics: a possible mitigator of age-related pulmonary disease
por: eBioMedicine
Publicado: (2023) -
From cell senescence to age-related diseases: differential mechanisms of action of senescence-associated secretory phenotypes
por: Byun, Hae-Ok, et al.
Publicado: (2015) -
Drugs against metabolic diseases as potential senotherapeutics for aging-related respiratory diseases
por: Matsubayashi, Sachi, et al.
Publicado: (2023) -
The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets
por: Rossi, Martina, et al.
Publicado: (2021)